No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
417 |
4. Check minimum number of eventsNone |
417 |
5. Include endpointsNone |
417 |
6. Filter based on genotype QC (FinnGen only) |
417 |
Control definitions (FinnGen only)
- Control exclude
- D3_COAGDEF_PURPUR_HAEMORRHAGIC
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D69
- Name in latin
- Thrombocytopenia secundaria
Similar endpoints
↥List of similar endpoints to
Secondary thrombocytopenia
based on the number of shared cases.
Similar with more cases:
- Purpura and other haemorrhagic conditions
- Coagulation defects, purpura and other haemorrhagic conditions
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3098 | 1537 | 1524 |
| Only index persons | 2347 | 1177 | 1170 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 61.19 | 61.53 | 60.87 |
| Only index persons | 60.76 | 60.97 | 60.54 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 417 | 218 | 199 |
| Unadjusted period prevalence (%) | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | 61.30 | 60.07 | 62.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 387
- Matched controls
- 3869
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D69.5
ICD-10 Finland
Secondary thrombocytopenia
+∞
323.0
360
*
WW500
NOMESCO Finland
Blood transfusion
35.7
107.6
141
61
D70.82
ICD-10 Finland
Drug-induced neutropenia
73.3
105.3
118
23
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
528.7
87.8
84
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
19.3
75.5
120
88
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
21.7
66.4
100
61
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.1
55.6
130
203
XW000
NOMESCO Finland
Bone marrow biopsy
15.7
51.9
88
71
H02AB02
ATC
dexamethasone; systemic
7.4
46.3
124
231
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
13.1
45.8
84
80
A03FA01
ATC
metoclopramide; systemic, rectal
5.3
44.7
171
499
ZX120
NOMESCO Finland
Intravenous
7.8
44.6
113
193
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
18.0
43.5
69
46
JN4BD
NOMESCO Finland
Extensive body CT
7.1
43.1
119
229
N02AA05
ATC
oxycodone; systemic
5.9
41.3
135
322
L03AA13
ATC
pegfilgrastim; parenteral
13.8
40.6
72
63
L03AA14
ATC
lipegfilgrastim; parenteral
24.9
39.7
56
26
L03AA02
ATC
filgrastim; parenteral
18.3
38.9
61
39
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
+∞
38.2
36
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
42.2
36.5
45
12
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.3
36.5
132
347
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.8
34.8
79
110
Z51.5
ICD-10 Finland
Palliative care
8.8
33.7
76
104
A04AA01
ATC
ondansetron; systemic, rectal
7.3
32.1
83
140
R50.9
ICD-10 Finland
Fever, unspecified
4.9
29.9
112
297
M04AA01
ATC
allopurinol; systemic
5.0
28.1
101
255
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
27.3
192
873
A04AA02
ATC
granisetron; systemic, transdermal
7.2
26.7
68
111
JN4AD
NOMESCO Finland
Body CT examination
5.9
25.9
78
159
D64.9
ICD-10 Finland
Anaemia, unspecified
5.4
25.3
83
187
H02AB06
ATC
prednisolone; systemic
3.1
24.3
228
1235
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
24.1
223
1193
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
18.2
22.7
35
21
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.2
21.6
46
56
WW300
NOMESCO Finland
Transfer of autologic stem cells
53.2
21.4
25
5
B01AB10
ATC
tinzaparin; parenteral
5.9
21.4
63
124
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.6
19.3
59
121
128
Kela drug reimbursment
Cancers of female genital organs
15.2
18.9
31
22
28711
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia symptomatica
+∞
18.9
18
*
B03XA02
ATC
darbepoetin alfa; parenteral
12.3
18.9
34
30
JN6AD
NOMESCO Finland
CT of torso and neck
13.8
18.8
32
25
C83.1
ICD-10 Finland
Mantle cell lymphoma
105.2
18.7
20
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
23.1
18.4
26
12
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
21.3
18.0
26
13
A41.9
ICD-10 Finland
Sepsis, unspecified
8.2
17.4
39
52
ZX112
NOMESCO Finland
Subcutaneous
12.4
17.3
31
27
130
Kela drug reimbursment
Malignant tumour
4.5
17.0
64
164
A02BC02
ATC
pantoprazole; systemic
2.6
16.7
282
1957
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
16.2
115
487
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
18.2
15.8
24
14
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
15.6
158
823
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
17.0
15.4
24
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.5
15.2
46
93
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
15.2
83
292
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.8
15.0
38
61
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.6
15.0
35
50
YNB10
NOMESCO Finland
Collection of stem cells for transplant
155.6
14.6
15
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.6
14.3
25
21
B01AB05
ATC
enoxaparin; parenteral
2.4
13.4
141
736
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
12.8
13.3
23
19
C03CA01
ATC
furosemide; systemic
2.5
13.2
134
686
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.8
12.6
55
161
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
15.0
12.4
20
14
A04AA55
ATC
palonosetron, combinations; systemic
6.6
12.3
31
50
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
12.2
56
171
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.9
12.2
40
89
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
27.7
12.1
16
6
ZX108
NOMESCO Finland
Inhalation
22.1
12.1
17
8
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
14.0
12.1
20
15
TGC00
NOMESCO Finland
Bronchial lavation
7.8
11.9
27
37
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
13.1
11.8
20
16
WW409
NOMESCO Finland
Other aferesis
31.1
11.7
15
5
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.1
11.5
36
76
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
11.4
62
214
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
36.2
11.3
14
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
20.8
11.2
16
8
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.9
11.2
47
133
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
11.0
65
237
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.1
11.0
34
71
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
11.0
10.9
20
19
J01MA12
ATC
levofloxacin; systemic
2.5
10.8
92
424
R18
ICD-10 Finland
Ascites
13.4
10.8
18
14
TK800
NOMESCO Finland
Hemodialysis
6.7
10.5
26
41
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.2
10.5
32
66
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
10.1
107
548
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
17.3
9.9
15
9
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
17.3
9.9
15
9
JN4CD
NOMESCO Finland
Very extensive body CT
5.1
9.7
30
63
127
Kela drug reimbursment
Transplant complication
9.5
9.6
19
21
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
15.5
9.6
15
10
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
9.5
44
136
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
12.8
9.4
16
13
ZXC40
NOMESCO Finland
Use of ultrasound
22.3
9.4
13
6
WZC30
NOMESCO Finland
Teaching
2.7
9.3
65
266
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.2
9.3
35
90
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
8.6
9.2
19
23
1XC02
NOMESCO Finland
NA
16.1
9.1
14
9
L01AX03
ATC
temozolomide; systemic
19.1
9.0
13
7
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
24.7
9.0
12
5
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
24.7
9.0
12
5
J05AB11
ATC
valaciclovir; oral
2.7
8.9
64
265
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.7
8.7
24
44
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
8.7
60
241
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.5
8.7
18
22
212
Kela drug reimbursment
Gout
7.2
8.7
20
29
B01AX05
ATC
fondaparinux; parenteral
16.7
8.6
13
8
L04AA06
ATC
mycophenolic acid; systemic
6.7
8.6
21
33
D68.8
ICD-10 Finland
Other specified coagulation defects
92.0
8.4
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
8.4
43
144
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
8.4
8
*
2874X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Secondary thrombocytopenia[THROMBOCYTOPENIA SECUNDARIA NUD]
+∞
8.4
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.5
8.2
28
66
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
8.2
96
510
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
17.6
8.1
12
7
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
22.6
8.1
11
5
JAL30
NOMESCO Finland
Omentectomy
8.0
8.0
17
22
J01MA14
ATC
moxifloxacin; systemic
2.9
7.9
47
174
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.7
7.9
16
19
A06AD11
ATC
lactulose; oral
2.5
7.9
64
284
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.3
7.7
27
66
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
18.8
7.6
11
6
ZXE00
NOMESCO Finland
One hour or less
1.9
7.5
158
1050
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
81.6
7.4
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
13.7
7.4
12
9
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
7.4
48
188
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
7.4
42
151
L04AX01
ATC
azathioprine; systemic
4.1
7.3
27
69
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
7.3
7
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
7.2
66
312
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
6.8
7.2
17
26
A04AD12
ATC
aprepitant; systemic
6.8
7.2
17
26
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
8.2
7.2
15
19
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
20.5
7.2
10
5
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.5
7.2
24
56
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
12.3
7.1
12
10
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
10.3
7.1
13
13
ZXD05
NOMESCO Finland
Urgent procedure
1.9
7.0
128
801
N03AX14
ATC
levetiracetam; systemic
4.8
7.0
22
48
JAH00
NOMESCO Finland
Laparotomy
5.7
7.0
19
35
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.7
7.0
19
35
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
6.9
114
689
H02AB07
ATC
prednisone; oral
2.3
6.9
63
296
A02BC01
ATC
omeprazole; systemic
1.9
6.9
109
648
TAB00
NOMESCO Finland
Lumbar puncture
3.6
6.9
29
84
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
6.9
68
334
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
6.8
53
231
E0000UV
ATC
NA
1.8
6.8
151
1011
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
17.1
6.8
10
6
WF004
NOMESCO Finland
Palliative radiotherapy
7.4
6.8
15
21
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.6
6.7
16
25
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.7
6.7
18
33
WX892
NOMESCO Finland
Monitored bed care
3.0
6.7
38
137
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.6
6.4
21
48
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
71.0
6.4
7
*
3009
Kela drug reimbursment
Niraparib
71.0
6.4
7
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
71.0
6.4
7
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
6.4
28
84
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.7
6.4
20
44
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.7
6.4
17
31
N05BA06
ATC
lorazepam; systemic, sublingual
3.7
6.3
26
74
JAH01
NOMESCO Finland
Laparoscopy
3.7
6.3
26
74
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
6.3
74
390
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
7.2
6.3
14
20
ZX131
NOMESCO Finland
Intrathecal
+∞
6.3
6
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
6.3
6
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.1
117
739
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.7
6.1
25
71
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
12.8
6.1
10
8
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
5.7
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012095) Magnesium [Moles/volume] in Serum or Plasma
205
552
6.34
77.90
9.5
3.4
mmol/l
0.8
0.8
2.65
200
524
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
52
21
28.15
74.98
6.0
3.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
99
133
9.45
72.84
3.2
1.9
ug/l
5.0
4.0
0.13
94
121
(3042111) Morphology [Interpretation] in Bone marrow Narrative
68
54
14.85
71.76
2.1
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
69
57
14.31
71.13
8.7
4.4
iu/ml
222.6
142.9
—
10
7
(3023368) Bacteria identified in Blood by Culture
257
903
5.81
70.52
9.2
4.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
138
279
6.90
70.09
6.3
4.3
%
1.7
1.0
2.20
98
87
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
57
43
15.20
61.69
4.4
2.6
u/ml
7368.0
697.4
—
7
5
(3023520) Reticulocytes [#/volume] in Blood
126
262
6.46
61.54
4.3
2.3
e9/l
80.8
68.8
1.99
107
204
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
84
128
7.97
54.90
1.8
1.6
g/l
1.6
1.5
0.09
70
113
(3021879) Hepatitis B virus core Ab [Presence] in Serum
109
222
6.29
53.89
1.7
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
140
359
5.37
53.65
2.0
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
116
253
5.97
53.30
5.8
2.4
g/l
9.3
10.6
1.86
110
229
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
108
229
6.02
51.00
3.0
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
37
18
22.46
49.25
2.7
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
114
264
5.57
48.71
6.1
4.3
%
0.5
0.2
1.42
79
80
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
154
459
4.73
48.56
2.0
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
41
27
16.73
47.46
4.6
2.1
e6/l
313.5
800.3
—
6
12
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
36
18
21.80
47.34
2.5
2.3
%
17.6
11.1
—
18
9
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
39
24
17.82
46.68
8.2
2.5
%
26.9
46.7
—
7
7
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
88
8.26
44.05
7.3
2.4
u/ml
0.3
0.3
0.09
40
40
(3011412) CD3 cells [#/volume] in Blood
40
29
15.15
43.93
3.0
2.1
e9/l
1.0
1.0
0.09
31
12
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
59
77
8.76
43.63
2.4
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
59
79
8.53
42.70
2.4
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
41
33
13.67
42.40
1.9
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
48
54
9.92
39.72
2.4
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
50
62
9.03
38.39
2.0
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
49
10.17
38.11
1.7
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
278
1458
3.72
36.08
12.4
4.5
g/l
32.2
35.7
17.16
272
1367
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
51
70
8.16
36.00
1.3
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
88
209
5.07
35.83
2.7
1.5
g/l
1.2
1.4
0.47
82
191
(40765096) Chromosome analysis panel by Banding
25
10
26.53
35.58
1.3
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
58
95
6.93
34.95
2.1
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
291
1592
3.74
34.90
14.2
5.8
%
9.6
8.7
3.09
284
1498
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
45
55
9.05
34.87
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
149
536
3.77
34.72
2.1
1.8
—
—
—
0
0
(4035726)
107
306
4.36
34.44
1.8
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
300
1689
3.77
34.04
14.2
5.6
e9/l
0.6
0.6
0.86
282
1458
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
44
54
8.99
33.97
1.6
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
293
1627
3.69
33.94
14.2
5.7
%
25.3
27.9
2.49
286
1522
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
41
46
9.78
33.89
1.9
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
300
1696
3.74
33.66
14.1
5.6
e9/l
0.0
0.0
4.09
282
1466
(3019198) Lymphocytes [#/volume] in Blood
303
1732
3.74
33.23
14.5
5.6
e9/l
1.5
1.9
7.41
287
1530
(3020630) Protein [Mass/volume] in Serum or Plasma
96
261
4.48
32.91
5.3
2.9
g/l
64.2
67.1
2.95
91
242
(3013115) Eosinophils [#/volume] in Blood
304
1750
3.72
32.77
15.0
5.9
e9/l
0.1
0.2
4.82
288
1546
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
42
51
9.05
32.67
2.2
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
41
49
9.17
32.28
1.6
1.3
u/ml
98.7
93.6
—
6
7
(3004809) Band form neutrophils/100 leukocytes in Blood
42
52
8.87
32.17
4.7
3.0
%
0.9
1.1
0.17
37
43
(44790049)
37
39
10.31
31.96
1.8
1.5
—
—
—
0
0
(44790047)
37
39
10.31
31.96
1.8
1.5
—
—
—
0
0
(44806118)
37
39
10.31
31.96
1.8
1.5
—
—
—
0
0
(44790048)
37
39
10.31
31.96
1.8
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
33
30
11.86
31.48
2.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
33
30
11.86
31.48
2.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
33
30
11.86
31.48
2.4
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
286
1610
3.47
31.41
13.2
5.5
%
57.7
57.1
0.30
281
1513
(3013650) Neutrophils [#/volume] in Blood by Automated count
324
1971
3.89
31.40
38.8
9.1
e9/l
3.5
4.1
4.25
312
1733
(3000093) Morphology [Interpretation] in Blood Narrative
31
26
12.80
31.09
1.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
92
253
4.38
30.95
5.8
4.2
%
1.0
0.5
1.26
51
64
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
38
44
9.40
30.62
2.1
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
225
1112
3.22
30.57
12.9
5.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
307
1823
3.59
30.50
22.6
6.2
umol/l
11.5
11.7
0.07
307
1730
(3022096) Basophils/100 leukocytes in Blood
276
1539
3.35
30.42
13.4
5.6
%
0.7
0.7
0.09
269
1437
(3006504) Eosinophils/100 leukocytes in Blood
281
1585
3.37
30.34
13.8
5.6
%
2.5
2.9
1.05
274
1478
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
33
32
11.11
30.16
2.0
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
35
37
10.23
30.14
2.0
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
27
19
15.13
29.90
1.4
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
34
35
10.49
29.82
1.9
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
257
1385
3.23
29.82
13.4
8.1
inr
1.2
1.2
0.25
90
393
(3042936) Bacteria identified in Isolate by Culture
134
492
3.54
29.67
2.5
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
77
190
4.74
29.66
2.1
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
41
55
8.16
29.38
1.2
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
90
254
4.24
29.15
6.4
4.3
%
0.1
0.1
0.13
55
66
(3044640) Blood type and Crossmatch panel - Blood
220
1096
3.13
29.08
5.4
2.3
—
—
—
0
0
(3020891) Body temperature
62
130
5.43
28.86
8.6
5.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
175
768
3.20
28.79
14.7
4.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
40
54
8.09
28.49
1.3
1.2
u/ml
295.1
179.5
1.87
29
27
(3018418) pH of Serum or Plasma
208
1018
3.08
28.13
12.0
3.7
ph
7.4
7.4
0.04
57
196
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
269
1521
3.17
28.08
16.5
5.8
mmol/l
1.2
1.2
7.63
258
1392
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
284
1664
3.22
27.69
20.0
6.5
mmol/l
1.2
1.2
4.73
245
1416
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
111
378
3.64
27.38
2.4
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
33
37
9.60
27.18
2.6
1.5
pg
34.7
33.0
1.09
33
37
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
136
531
3.32
26.97
2.7
1.8
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
27
24
11.96
26.04
2.7
2.2
e6/l
545.4
548.9
0.01
21
19
(3048929) Epstein Barr virus Ab [Presence] in Serum
49
91
5.97
25.90
1.3
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
231
1241
2.93
25.70
5.3
3.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
107
372
3.52
25.40
2.3
1.8
—
—
—
0
0
(3036489) Thrombin time
53
109
5.42
25.11
5.2
2.3
s
22.8
21.8
0.52
48
99
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
272
1621
2.95
24.47
9.3
3.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
215
1143
2.82
23.90
8.5
3.3
mmol/l
2.3
2.4
5.52
202
1007
(40758558) Short blood count panel - Blood
176
844
2.88
23.81
33.3
6.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
26
25
11.03
23.79
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
119
460
3.22
23.64
3.7
2.2
%
26.8
23.1
1.17
109
397
(3026782) Osmolality of Urine
150
664
2.97
23.48
3.7
2.7
mosm/kgh2o
554.5
567.0
0.28
138
557
(3000991) Gas panel - Venous blood
87
282
3.63
22.82
12.1
8.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
106
392
3.28
22.57
2.0
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
154
710
2.85
22.15
3.3
2.6
e6/l
4.2
4.8
0.52
136
621
(3002032) Base excess in Venous blood by calculation
90
304
3.50
22.12
8.2
3.7
mmol/l
2.6
2.1
0.59
76
239
(3003396) Base excess in Arterial blood by calculation
104
393
3.19
21.25
11.9
7.9
mmol/l
1.7
1.2
0.46
86
318
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
91
317
3.39
21.25
3.8
2.4
g/l
0.2
0.2
3.26
86
297
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
166
816
2.72
20.86
4.7
2.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
72
220
3.75
20.50
3.8
2.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
19
0
+∞
19.95
1.4
0.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
181
954
2.59
19.46
4.7
3.1
e6/l
0.5
0.4
0.39
160
707
(3002173) Hemoglobin [Mass/volume] in Arterial blood
89
324
3.22
19.22
13.3
8.7
g/l
108.9
121.7
6.99
89
312
(40768795) Lymph node Pathology biopsy report
25
31
8.52
18.95
1.3
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
24
29
8.72
18.56
1.3
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
189
1046
2.48
17.97
4.7
3.2
e6/l
28.2
110.1
0.71
168
798
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
37
7.43
17.58
4.2
3.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
178
966
2.47
17.57
3.9
2.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
68
224
3.43
17.16
10.0
4.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
45
111
4.42
17.06
2.3
2.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
157
815
2.49
16.96
2.8
2.0
mg/l
3.3
3.0
0.85
150
715
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
27
8.55
16.78
1.2
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
23
30
8.06
16.71
2.4
2.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
191
1089
2.39
16.68
3.9
2.5
u/l
53.9
56.6
0.40
184
1004
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
37
7.12
16.31
2.1
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
239
1513
2.36
16.26
26.5
9.1
e9/l
0.0
0.0
0.54
216
1240
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
82
4.85
15.97
1.8
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
294
2056
2.46
15.64
12.4
4.6
mmol/l
6.8
6.7
0.17
285
1920
(3025941) Bacteria identified in Stool by Culture
59
193
3.40
14.98
1.6
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
200
1205
2.27
14.89
5.4
3.7
e6/l
131.3
67.4
0.54
176
855
(36304419) Bacteria [Presence] in Urine
166
930
2.30
14.67
4.2
3.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
31
64
5.15
14.50
5.2
3.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
18
7
26.77
13.47
2.8
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
137
729
2.31
13.47
4.4
1.8
mg/l
4.2
1.2
2.18
120
574
(40761535) Cells panel - Urine sediment
72
284
2.86
13.24
5.7
3.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
6
29.44
13.06
3.0
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
39
107
3.92
12.80
4.1
2.3
ug/l
318.1
780.6
0.55
34
99
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
16
9.69
12.62
2.2
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
168
993
2.16
12.60
4.3
3.0
ng/l
1578.7
966.8
1.19
155
843
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
73
4.51
12.42
1.5
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
23
7.66
11.92
1.4
1.5
e6/l
30611.8
30471.0
—
11
10
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
78
339
2.60
11.82
6.9
3.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
41
5.61
11.47
1.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
29
69
4.44
11.46
2.3
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
203
1324
2.04
11.41
5.0
3.6
ng/l
33.6
42.1
0.66
169
933
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
62
248
2.76
11.03
5.2
3.6
ng/l
112.2
74.8
2.18
56
224
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
82
377
2.46
11.00
3.6
4.5
ug/l
17.6
18.7
0.03
71
316
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
17
8.49
10.67
2.3
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
26
60
4.55
10.67
6.1
3.1
e9/l
3.6
4.3
0.61
26
60
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
20
7.74
10.62
2.2
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
61
4.48
10.45
8.0
3.6
%
56.7
57.6
0.09
26
61
(3024471) HLA-A [Type]
15
8
19.39
10.33
1.0
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
34
5.81
10.31
2.7
2.5
%
57.2
55.2
0.09
13
24
(3003694) ABO and Rh group [Type] in Blood
157
965
2.01
10.13
1.7
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
294
2242
2.06
10.10
6.7
4.3
e6/l
10.5
3805.2
—
8
44
(3012501) Base excess in Blood by calculation
28
72
4.10
10.02
6.6
4.0
mmol/l
2.2
2.2
0.01
21
48
(3029937) Albumin [Presence] in Urine by Test strip
150
910
2.01
10.02
7.1
4.0
estimate
0.0
0.0
0.50
61
303
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
25
6.62
9.88
2.6
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
25
6.62
9.88
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
19
36
5.48
9.72
1.1
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
30
84
3.77
9.56
1.7
1.2
mg/l
509.9
462.3
0.20
30
76
(3001122) Ferritin [Mass/volume] in Serum or Plasma
210
1452
1.90
9.36
4.0
2.6
ug/l
363.5
121.2
7.18
205
1348
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
30
5.87
9.35
6.5
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
15
8.21
8.90
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
48
4.55
8.71
1.1
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
25
6.19
8.71
1.1
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
80
401
2.23
8.70
28.4
6.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
131
791
1.96
8.66
1.8
1.5
nmol/l
18.1
21.2
1.67
122
670
(3007164) IgA [Mass/volume] in Serum or Plasma
113
651
2.01
8.53
2.7
1.4
g/l
2.3
2.6
0.60
95
398
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
6
20.53
8.51
1.2
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
33
107
3.26
8.45
2.7
1.8
g/l
0.9
1.0
0.03
26
97
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
105
591
2.04
8.45
4.2
2.7
e6/l
1.3
0.9
0.66
78
338
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
83
3.54
8.23
2.1
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
173
1168
1.82
7.95
7.7
3.3
u/l
41.7
33.2
1.57
168
1111
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
60
276
2.37
7.94
10.3
2.3
ml/min/173m2
57.1
66.9
1.07
24
119
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
30
96
3.29
7.85
2.5
1.6
g/l
0.0
0.0
0.00
25
91
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
29
91
3.35
7.82
2.5
1.6
g/l
0.0
0.0
0.00
24
86
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
40
152
2.80
7.80
9.1
3.7
mmol/l
24.6
24.4
0.17
35
142
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
26
76
3.58
7.80
1.7
1.1
mmol/l
3.9
4.0
0.23
26
69
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
31
102
3.20
7.76
7.4
4.0
mg/l
28.2
31.5
0.15
25
83
(3034860) Kappa light chains.free [Mass/volume] in Serum
31
102
3.20
7.76
7.4
4.0
mg/l
61.0
115.6
0.40
25
82
(3024932) HLA-DR beta [Type]
12
8
15.39
7.76
1.5
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
53
4.12
7.71
1.5
1.2
u/ml
3.3
1.3
0.78
14
14
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
119
3.02
7.68
2.8
1.5
g/l
9.5
10.5
0.50
29
104
(40758292) HTLV I+II Ab panel - Serum
11
6
18.78
7.64
1.2
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
131
2.91
7.60
3.1
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
131
2.91
7.60
3.1
1.6
g/l
3.4
3.8
1.42
25
93
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
131
2.91
7.60
3.1
1.6
g/l
7.5
7.5
0.01
26
97
(3009261) Glucose [Presence] in Urine by Test strip
229
1705
1.76
7.37
6.5
3.7
estimate
0.0
0.0
0.00
65
298
(40761536) Microorganisms panel - Urine sediment
59
279
2.30
7.32
6.4
4.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
57
266
2.32
7.29
1.5
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
19
6.47
7.28
1.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
75
3.48
7.22
7.9
4.6
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
10
5
20.44
7.16
2.2
1.0
%
269.4
185.4
—
10
5
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
30
102
3.09
7.12
2.9
1.6
g/l
36.2
37.8
0.85
25
90
(3022217) INR in Platelet poor plasma by Coagulation assay
80
432
2.05
7.12
22.0
18.4
inr
1.5
1.3
—
5
60
(3021601) Nitrite [Presence] in Urine by Test strip
226
1689
1.74
7.07
8.3
4.9
estimate
0.0
0.0
0.50
68
308
(3035350) Ketones [Presence] in Urine by Test strip
224
1674
1.73
6.97
6.7
3.6
estimate
0.0
0.0
0.00
62
308
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
83
3.27
6.84
1.2
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
68
3.52
6.79
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
99
587
1.90
6.71
1.9
1.7
nmol/l
1320.9
1225.6
0.40
87
457
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
111
685
1.85
6.64
1.6
1.7
pmol/l
507.3
435.0
1.02
104
578
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
101
3.01
6.61
1.9
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
28
96
3.05
6.56
1.4
1.4
ug/g
276.6
272.0
0.04
19
59
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
56
3.70
6.39
1.5
1.2
u/ml
8.0
3.8
0.65
14
23
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
121
2.78
6.31
3.2
1.6
g/l
3.5
3.2
0.72
25
94
(3008536) Aspergillus sp Ab [Presence] in Serum
9
5
18.35
6.29
4.9
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
5
18.35
6.29
1.3
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
48
222
2.31
6.26
4.2
3.5
ph
7.4
7.4
—
7
21
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
43
4.08
6.23
1.4
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
46
211
2.33
6.12
4.0
3.5
mmol/l
2.0
1.9
0.06
37
152
(3037467) Urinalysis macro (dipstick) panel - Urine
286
2333
1.72
6.06
7.3
4.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
59
3.51
5.94
1.2
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
28
102
2.87
5.92
1.9
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
79
454
1.91
5.83
1.5
1.3
titre
903.6
469.4
0.76
22
102
(42529406) Shigella sp [Presence] in Stool by Culture
28
103
2.84
5.82
1.9
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
60
3.45
5.79
3.2
2.5
%
16.7
16.5
—
9
27
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
91
551
1.83
5.71
4.4
2.9
e6/l
3.6
2.0
0.88
64
301
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
82
3.04
5.67
1.3
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
11
21
5.35
5.55
1.5
1.9
umol/l
12.3
12.8
0.12
11
21
(3000494) Fungus identified in Specimen by Culture
74
426
1.90
5.42
2.5
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
117
775
1.71
5.36
6.4
3.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
10
18
5.67
5.34
1.0
1.2
u/l
12.0
16.4
—
10
18
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
85
2.93
5.34
2.7
2.0
u/l
99.9
5142.5
0.84
16
31
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
30
4.44
5.33
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
22
5.11
5.29
1.9
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
11
22
5.11
5.29
1.1
1.3
u/l
816.4
258.8
0.78
11
22
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
177
1315
1.60
5.13
7.4
3.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
6
13.56
5.10
4.5
2.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
29
117
2.59
5.08
5.2
2.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
39
181
2.27
5.06
4.1
2.8
e6/l
0.3
0.1
0.46
39
175
(40768804) Tissue Pathology biopsy report
182
1366
1.59
5.02
2.4
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
310
3463
0.59
4.90
4.7
5.1
mmol/l
2.6
2.8
1.32
289
3207
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
26
101
2.68
4.90
1.6
1.6
iu/ml
0.0
0.0
—
8
18
(40768806) Pleura Pathology biopsy report
12
28
4.38
4.85
1.1
1.6
—
—
—
0
0
(4281824)
14
37
3.88
4.85
1.3
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
15
42
3.67
4.81
2.5
1.7
%
87.8
90.8
0.95
15
42
(3016018) Differential panel - Cerebral spinal fluid
11
24
4.68
4.81
1.4
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
115
2.54
4.74
7.1
4.5
g/l
0.3
0.2
0.38
23
44
(40768441) Liver Pathology biopsy report
12
29
4.23
4.65
1.7
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
11
8.33
4.58
1.9
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
25
101
2.57
4.38
4.8
2.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
61
3.04
4.33
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
61
3.04
4.33
1.3
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
61
3.04
4.33
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
22
4.63
4.32
1.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
9
9.03
4.29
1.0
1.2
—
—
—
0
0
(4268621)
14
41
3.50
4.22
3.2
2.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
10
8.13
4.07
2.1
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
7
10.14
4.02
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
59
2.96
3.94
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
308
3407
0.63
3.88
4.6
4.5
mmol/l
4.5
4.7
1.88
288
3175
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
282
3176
0.65
3.84
6.6
5.8
mmol/mol
40.3
40.0
0.27
262
2969
(3021901) Oxygen saturation in Capillary blood
17
60
2.91
3.84
3.5
2.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
15
6.11
3.83
3.3
4.1
%
80.1
88.6
—
9
15
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
306
3387
0.64
3.82
4.5
4.5
mmol/l
1.3
1.5
5.42
283
3136
(3000330) Specific gravity of Urine by Test strip
35
175
2.09
3.82
6.2
3.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
8
8.87
3.78
2.0
2.9
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
5
12.15
3.77
1.5
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
50
3.07
3.72
2.9
2.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
9
7.89
3.57
3.9
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
46
3.11
3.56
2.6
3.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
13
41
3.24
3.52
2.2
2.3
ug/l
21.1
17.6
0.32
13
41
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
6
10.12
3.50
1.8
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
53
2.90
3.39
1.6
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
170
1339
1.46
3.39
2.3
1.9
pmol/l
88.1
93.8
1.15
119
691
(3000012) Reticulocyte production index
9
18
5.08
3.39
1.3
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
18
5.08
3.39
1.3
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
7
8.67
3.27
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
49
2.92
3.22
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
302
3324
0.67
3.21
5.0
4.6
mmol/l
5.9
6.0
0.17
280
3067
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
15
5.41
3.20
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
8
15
5.41
3.20
1.6
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
8
15
5.41
3.20
1.1
1.2
u/l
12.9
12.9
—
8
15
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
20
4.57
3.13
1.6
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
20
4.57
3.13
1.6
1.1
—
—
—
0
0
(4062490)
12
39
3.14
3.11
1.9
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
34
3.30
3.08
5.3
3.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
8
7.59
3.06
2.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
162
1.99
3.04
2.1
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
12
5.91
3.03
4.3
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
12
5.91
3.03
4.3
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
51
2.81
3.01
1.4
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
51
2.81
3.01
2.9
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
63
2.60
2.99
5.2
2.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
5
10.10
2.98
1.0
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
170
1367
1.41
2.92
2.9
2.3
nmol/l
75.5
76.9
0.25
161
1223
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
52
2.75
2.91
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
15
58
2.65
2.90
1.9
1.8
g/l
0.1
0.9
—
10
43
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
13
5.46
2.88
4.3
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
297
0.39
2.85
2.0
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
47
2.82
2.84
2.8
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
47
2.82
2.84
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
35
196
1.86
2.82
1.4
1.2
u/ml
555.5
162.3
1.06
29
181
(3051651) Icteric interference index of Serum or Plasma
9
23
3.97
2.79
5.7
2.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
48
2.76
2.74
2.8
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
48
2.76
2.74
2.8
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
48
2.76
2.74
2.8
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
14
5.07
2.74
1.3
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
14
5.07
2.74
1.3
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
91
660
1.48
2.69
4.1
3.7
ng/l
529.4
365.4
0.39
77
522
(3019150) Specific gravity of Urine by Refractometry
101
749
1.46
2.67
6.8
3.9
kg/l
1.0
1.0
—
8
102
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
32
3.18
2.66
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
49
2.71
2.64
2.8
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
87
2.24
2.61
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
15
4.73
2.60
1.1
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
68
953
0.66
2.57
1.6
1.7
mmol/l
1.6
1.4
0.62
56
802
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
56
2.55
2.55
1.4
1.6
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
11
5.51
2.55
10.0
3.7
u/l
195.5
194.4
—
6
11
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
11
5.51
2.55
1.7
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
11
5.51
2.55
1.7
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
274
2421
1.38
2.53
5.7
3.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
26
3.51
2.49
1.1
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
16
4.43
2.48
4.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
16
4.43
2.48
4.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
16
4.43
2.48
4.3
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
16
4.43
2.48
4.3
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
96
2.14
2.47
6.6
4.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
34
2.99
2.43
1.2
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
34
2.99
2.43
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
12
5.06
2.41
1.5
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
12
5.06
2.41
1.0
1.0
miu/ml
1400.2
1391.6
—
6
12
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
12
5.06
2.41
4.7
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
27
3.38
2.40
1.4
1.7
—
—
—
0
0
(4306422)
13
52
2.55
2.38
1.4
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
8
6.31
2.38
1.2
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
301
3269
0.72
2.36
4.5
4.1
mmol/l
1.4
1.3
2.20
280
3020
(3022313) Gas panel - Capillary blood
30
171
1.81
2.31
4.8
3.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
41
2.73
2.29
1.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
13
4.67
2.28
2.7
1.7
ug/l
58.5
67.0
—
6
13
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
9
5.61
2.22
1.4
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
9
5.61
2.22
1.4
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
9
5.61
2.22
1.6
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
9
5.61
2.22
1.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
48
2.54
2.20
2.9
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
42
2.66
2.20
1.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
19
3.73
2.16
1.7
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
19
3.73
2.16
1.7
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
363
3408
1.50
2.09
50.2
13.7
mg/l
28.4
23.2
2.47
341
2672
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
20
3.54
2.06
1.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
61
432
1.48
2.03
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
157
1.77
1.98
2.9
2.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
66
479
1.45
1.95
1.3
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
16
3.79
1.94
2.8
2.3
u/ml
908.3
824.2
—
6
16
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
48
327
1.53
1.92
3.4
2.3
u/l
28.6
32.4
0.56
42
272
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
182
1.70
1.91
24.8
9.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
19
100
1.94
1.88
1.3
1.2
u/ml
1.5
3.0
—
5
14
(3051611) Lipemic interference index of Serum or Plasma
9
34
2.68
1.87
5.8
2.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
34
2.68
1.87
1.6
1.1
—
—
—
0
0
(3013512) EKG study
125
1017
1.33
1.85
5.1
3.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
26
153
1.75
1.84
4.6
3.5
u/ml
736.4
1210.5
0.17
20
129
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
19
101
1.92
1.84
1.3
1.2
u/ml
2.3
2.8
—
5
17
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
12
4.20
1.83
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
30
2.70
1.73
1.6
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
30
2.70
1.73
1.6
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
13
3.88
1.72
3.2
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
339
0.57
1.69
1.6
2.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
31
2.61
1.66
1.8
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
365
3796
0.69
1.62
76.0
20.4
g/l
118.9
136.2
55.70
365
3744
(3001019) Free T4 and TSH panel - Serum or Plasma
7
156
0.44
1.58
1.1
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
35
238
1.51
1.45
5.0
2.4
e9/l
3.5
3.9
0.43
26
189
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
16
3.15
1.44
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
22
2.75
1.44
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
6
22
2.75
1.44
2.5
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
22
2.75
1.44
1.2
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
142
1.66
1.41
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
96
1.80
1.41
1.9
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
29
2.44
1.40
1.0
1.1
—
94.4
—
0
5
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
82
1.86
1.37
2.5
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
120
1008
1.27
1.36
3.8
3.2
mg/l
655.3
174.2
0.42
80
652
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
17
2.96
1.36
2.8
1.6
umol/l
60.6
49.2
—
5
12
(3047189) Immunofixation for 24 hour Urine
5
17
2.96
1.36
1.8
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
23
144
1.63
1.35
1.8
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
83
1.84
1.33
1.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
304
0.61
1.32
1.6
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
106
1259
0.79
1.32
3.2
2.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
34
2.38
1.30
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
55
2.03
1.28
2.7
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
8
35
2.31
1.27
1.3
1.5
mosm/kgh2o
277.8
278.4
—
8
24
(3009214) Lutropin [Units/volume] in Serum or Plasma
15
85
1.79
1.24
1.5
1.4
u/l
9.5
9.0
0.05
15
72
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
200
0.54
1.22
1.5
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
126
1078
1.24
1.21
3.6
3.2
mmol/l
6.6
7.8
2.54
104
895
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
86
1.77
1.20
1.3
1.4
miu/ml
280.3
286.1
—
7
41
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
40
2.02
1.12
3.9
3.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
96
1.69
1.11
1.2
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
111
946
1.24
1.10
6.4
3.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
123
1061
1.23
1.09
4.8
4.0
mg/mmol
24.0
7.1
1.87
80
668
(3044242) Glucose [Moles/volume] in Arterial blood
5
21
2.40
1.09
2.0
4.7
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
21
2.40
1.09
1.4
1.4
u/field
1.0
0.8
—
5
13
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
14
82
1.73
1.06
1.5
1.2
u/ml
36.5
32.3
—
5
10
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
56
442
1.31
1.04
2.4
1.9
%
1.7
1.5
0.74
49
390
(36660697) Celiac disease serology panel - Serum
34
248
1.40
1.03
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
58
719
0.78
1.02
2.2
3.0
ug/l
0.8
0.7
0.24
35
469
(4027681)
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
23
2.19
0.98
3.2
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
247
2295
1.19
0.95
5.7
3.1
u/l
89.7
50.9
3.71
239
2150
(3022145) Colonoscopy Study observation
52
412
1.30
0.95
1.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
84
989
0.81
0.95
4.0
4.2
%
21.3
20.8
0.11
38
456
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
6
27
2.24
0.94
1.5
1.1
mg/l
71.0
39.3
—
6
22
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
27
2.24
0.94
2.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
28
2.16
0.92
1.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
86
728
1.23
0.91
1.2
1.3
u/ml
1.3
1.5
0.13
20
201
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
127
1.52
0.90
3.1
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
12
71
1.71
0.89
7.6
3.1
—
—
—
0
0
(3019225) pH of Specimen
40
309
1.33
0.88
12.1
4.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
30
2.01
0.87
1.7
1.2
promille
0.7
1.2
—
6
22
(3044927) Protein electrophoresis panel - Urine
6
32
1.89
0.82
2.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
391
0.75
0.78
1.7
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
40
1.76
0.71
2.0
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
41
1.72
0.70
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
10
156
0.63
0.68
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
42
1.68
0.68
1.4
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
78
1.55
0.66
2.1
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
299
3110
0.86
0.66
5.2
4.6
mu/l
2.2
1.9
1.53
276
2838
(3048689) Calprotectin [Mass/mass] in Stool
48
398
1.23
0.64
3.3
2.3
ug/g
257.3
130.4
0.96
37
316
(3045424) Erythrocytes [Presence] in Urine
8
51
1.58
0.60
1.8
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
47
559
0.82
0.60
1.1
1.3
u/ml
23.4
11.6
0.32
18
214
(3021788) Differential panel - Synovial fluid
8
53
1.52
0.58
1.8
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
89
1.48
0.58
1.3
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
25
318
0.77
0.57
1.1
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
54
1.49
0.57
1.4
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
5
87
0.57
0.57
1.4
1.8
—
7.9
—
0
26
(40768793) Breast Pathology biopsy report
5
88
0.56
0.56
1.2
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
64
559
1.17
0.52
1.4
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
49
569
0.84
0.50
1.2
1.3
iu/ml
15.3
31.2
2.27
20
186
(4010399)
19
244
0.77
0.48
1.2
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
121
0.65
0.46
1.6
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
192
1.27
0.46
2.4
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
50
1.41
0.45
1.6
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
50
1.41
0.45
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
121
1.34
0.45
2.1
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
51
1.38
0.44
1.3
1.6
—
—
—
0
0
(4034850)
16
122
1.32
0.43
14.1
10.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
92
0.65
0.43
1.2
1.4
—
—
—
0
0
(4211845)
0
16
0.00
0.41
0.0
3.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
292
0.81
0.41
1.1
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
430
0.85
0.40
4.4
4.5
%
27.1
32.1
1.82
30
291
(3002523) Influenza virus A Ag [Presence] in Specimen
8
61
1.32
0.39
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
61
1.32
0.39
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
147
0.74
0.38
1.5
2.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
41
1.47
0.36
1.3
1.6
u/l
67.5
28.1
—
6
35
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
126
1.28
0.35
1.6
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
27
229
1.19
0.33
1.3
1.3
—
47.0
—
0
13
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
116
1229
0.92
0.29
4.3
4.7
ug/l
2.8
2.3
0.31
108
1109
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
201
2082
0.93
0.27
3.2
2.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
77
1.31
0.26
1.6
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
74
1.22
0.25
1.6
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
77
1.17
0.24
2.7
1.6
—
—
—
0
0
(3000492) Spirometry study
29
325
0.88
0.22
1.2
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
41
1.22
0.22
1.0
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
13
0.00
0.21
0.0
4.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
155
0.83
0.20
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
50
1.20
0.20
1.3
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
90
1.23
0.19
2.3
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
60
1.17
0.18
1.6
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
11
91
1.21
0.17
1.5
1.6
mu/l
251.5
280.9
0.35
11
86
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
82
1.22
0.17
1.4
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
148
1.15
0.17
1.9
2.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
306
3100
0.95
0.15
40.2
14.6
%
36.4
40.1
8.87
191
2247
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
11
94
1.17
0.13
1.7
2.6
ug/min
33.4
75.8
—
5
53
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
85
1.18
0.12
1.0
1.1
—
8.2
—
0
11
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
85
1.18
0.12
2.6
1.9
pmol/l
171.4
231.8
—
10
78
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
228
0.92
0.10
1.1
1.2
iu/ml
191.6
129.4
—
10
89
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
107
1.13
0.08
2.7
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
58
1.03
0.08
1.7
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
58
1.03
0.08
1.7
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
66
1.06
0.08
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
66
1.06
0.08
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
66
1.06
0.08
1.6
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
66
1.06
0.08
1.6
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
74
0.81
0.07
1.2
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
324
3221
1.03
0.06
38.5
12.9
ml/min/173m2
78.0
81.2
1.46
304
2659
(3000764) Benzodiazepines [Presence] in Urine
12
111
1.08
0.04
2.7
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
256
2546
1.01
0.03
4.7
3.9
pmol/l
15.0
14.7
0.67
239
2305
(3027008) Opiates [Presence] in Urine
12
114
1.05
0.00
2.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
114
1.05
0.00
2.7
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
13
136
0.95
0.00
1.1
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
363
3632
1.00
0.00
56.1
16.3
umol/l
89.3
77.2
3.38
363
3632
(3013139) Helicobacter pylori Ag [Presence] in Stool
21
211
1.00
0.00
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
229
1.00
0.00
2.6
2.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
113
0.97
0.00
2.8
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
124
0.97
0.00
1.7
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
104
0.96
0.00
1.6
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
126
1.03
0.00
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
47
475
0.99
0.00
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
357
3574
0.99
0.00
41.2
12.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
31.6
—
0
5
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
198.0
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
13.4
—
161.1
—
0
5
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
22.3
—
0
9
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
56
0.89
0.00
1.4
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
8.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_SCNDTHROMBOCYTOPENIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_SCNDTHROMBOCYTOPENIA | 6.962 [5.14, 9.44] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.753 |
During the follow-up period (1.1.1998 — 31.12.2019), 515 out of 941 females with D3_SCNDTHROMBOCYTOPENIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_SCNDTHROMBOCYTOPENIA | 6.625 [4.83, 9.08] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 505 out of 932 males with D3_SCNDTHROMBOCYTOPENIA died.
Mortality risk
Mortality risk for people of age
years, who have D3_SCNDTHROMBOCYTOPENIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.688% | 0.814% |
| 5 | 4.254% | 6.786% |
| 10 | 9.942% | 17.034% |
| 15 | 19.081% | 30.032% |
| 20 | 33.067% | 46.714% |
Relationships between endpoints
↥Index endpoint: D3_SCNDTHROMBOCYTOPENIA – Secondary thrombocytopenia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data